WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax ... based coronavirus vaccine – and until now it had emergency authorization from FDA for use ...

Novavax's combo and standalone flu vaccines showed strong immune responses and good safety in a Phase 3 trial of adults 65 ...

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as ...

The agency approved the company's lower-dose Covid vaccine for older adults and young people with underlying medical ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the FDA’s attitude toward mRNA and COVID-19 vaccines that have investors ...

FDA Approves Novavax COVID-19 Shot but With Unusual Restrictions WASHINGTON (AP) — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...

Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to grant Novavax full approval – without restrictions ― by its April 1 target ...